Business documents

Opgen Inc Cmn Stk (NASDAQ:OPGN) shares traded -0.09% down during most recent session to reach at the closing price of $0.32. The stock exchanged hands 1.62 Million shares versus average trading capacity of 1.32 Million shares, yielding a market cap of $8.66 Million. Wall Street analysts covering the stock are projecting that the stock will reach $1.5 within the next 52-weeks. The mean target projections are based on 2 opinions.

Taking a broader look brokerage firms’ analysts on the street with an expectant view have Opgen Inc Cmn Stk (NASDAQ:OPGN) high price target of $2 and with a conservative view have low price target of $1.

Rodman & Renshaw “Initiates Coverage on” Opgen Inc Cmn Stk (NASDAQ:OPGN) in a research note issued to investors on 6/29/16 to Buy with price target of $2.5.

On the other hand the company has Relative Strength Index (RSI 14) of 35.35 along with Average True Range (ATR 14) of 0.05, Consequently Opgen Inc Cmn Stk (NASDAQ:OPGN)’s weekly and monthly volatility is 8.56%, 14.21% respectively. The company’s beta value is at 0.

In terms of Buy, Sell or Hold recommendations, Opgen Inc Cmn Stk (NASDAQ:OPGN) has analysts’ mean recommendation of 2. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.

According to analysts Opgen Inc Cmn Stk (NASDAQ:OPGN)’s minimum EPS for the current quarter is at $-0.14 and can go high up to $-0.13. The consensus mean EPS for the current quarter is at $-0.14 derived from a total of 2 estimates from the analysts who have weighed in on projected earnings. However the company reported $-0.23 earnings per share for the same quarter during last year.

Previously Opgen Inc Cmn Stk (NASDAQ:OPGN) reported $-0.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $-0.16 by $0.01. The company posted an earnings surprise of 6.3%.

Opgen Inc Cmn Stk (NASDAQ:OPGN)’s revenue estimates for the current quarter are $980 Million according to 2 number of analysts, for the current quarter the company has high revenue estimates of $1 Million in contradiction of low revenue estimates of $950 Million. For the current year the company’s revenue estimates are $3.36 Million compared to low analyst estimates of $3 Million and high estimates of $3.71 Million according to 2 number of analysts.

Currently Opgen Inc Cmn Stk (NASDAQ:OPGN)’s shares owned by insiders are 0.4%, whereas shares owned by institutional owners are 32%. However the six-month change in the insider ownership was recorded 0%, as well as three-month change in the institutional ownership was recorded 0%.

Opgen Inc Cmn Stk (NASDAQ:OPGN) 52-week high price stands at $3.10 and low price stands at $0.28, its price distance from 52-week high is -89.69% while its distance from 52-week low price is 12.93%. The stock hit its 52-week high on 12/13/16, and 52-week low on 07/31/17.

Opgen Inc Cmn Stk (NASDAQ:OPGN)’s trailing twelve month revenues are $3.7 Million, whereas its price to sales ratio for the same period is 2.34. Its book value per share for the most recent quarter is $0.02 while its price to book ratio for the same period is 15.98, as for as the company’s cash per share for the most recent quarter is $0.06, however its price to cash per share ratio for the same period is 5.09. The stock has 5 year expected PEG ratio of 0 whereas its trailing twelve month P/E ratio is 0.